NASDAQ, CPIX - Cumberland Pharmaceu
BUSINESS
OUR COMPANY
We are a growing specialty pharmaceutical company focused on the acquisition,
development and commercialization of branded prescription products. Our primary
target markets are hospital acute care and gastroenterology, which are
characterized by relatively concentrated physician prescriber bases that we
believe can be penetrated effectively by relatively small, targeted sales
forces. Cumberland is dedicated to providing innovative products which improve
quality of care for patients.
Our product portfolio includes Acetadote? (acetylcysteine) Injection for the
treatment of acetaminophen poisoning, Caldolor? (ibuprofen) Injection, the first
injectable treatment for pain and fever available in the United States, and
Kristalose? (lactulose) for Oral Solution, a prescription laxative. ...
Read SEC Filing on NASDAQ.com »